North America Pharmaceutical Drug Delivery Market is expected to reach US$ 26,253.37 Mn in 2027

Published Date: 13 Jun 2020

Report : North America Pharmaceutical Drug Delivery Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By  Route of Administration (Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Delivery, Transmucosal Drug Delivery, Implantable Drug Delivery); Application (Infectious Diseases, Cancer, Cardiovascular Diseases, Diabetes, Respiratory. Diseases, Central Nervous System Disorders, Autoimmune Diseases, and Other Diseases); End User (Hospitals, Home Care Settings, ASC/Clinics, Other End Users); and Country

Infectious Diseases Segment to Register Highest CAGR in North America Pharmaceutical Drug Delivery Market during 2020–2027

 

According to our new research study on “North AmericaPharmaceutical Drug DeliveryMarketForecast to 2027 - Covid-19 Impact and Regional Analysisby Route Of Administration, Application, and End User,”the North Americapharmaceutical drug delivery market is projectedto reach US$ 9,36,148.9million by2027 from US$ 5,60,491.5 million in2019. The market is estimated to grow at CAGR of 6.8% from 2020 to 2027. The report highlights trends prevailing in this marketalong with the drivers and restraints pertaining to the market.

 

The North Americapharmaceutical drug deliverymarket, based on application, is further segmented into infectious diseases, cancer, cardiovascular diseases, diabetes, respiratory diseases, central nervous system disorders, autoimmune diseases, and other applications.The cancer segment held the largest share of the market in 2019. However, the infectious diseases segment is estimated to register the highest CAGR during the forecast period. The projected growth of the market for this segment is attributed to the growing adoption of unhealthy practices and lack of preventive care. Increasing number of vaccines and medications being introduced by pharmaceutical companies, on the back of their growing involvement in partnerships and increasing focus on developments, are likely to drive the demand for drug delivery devices during the forecast period.

 

The growth of the North America pharmaceutical drug delivery marketis attributed to the increasing prevalence of chronic diseases in the region. However, the high cost of drug delivery device developmenthinders the growth of the market.Leading companies operating in the pharmaceutical drug delivery marketare3M, Antares Pharma, BD, Pfizer Inc., and Johnson & Johnson Services, Inc., among others.

North AmericaPharmaceutical Drug DeliveryMarket, By Country, 2019 (%)

North AmericaPharmaceutical Drug DeliveryMarket

 

 

The report segments North AmericaPharmaceutical Drug Delivery Market as follows:

 

By Route of Administration

  • Oral Drug Delivery
  • Injectable Drug Delivery
  • Topical Drug Delivery
  • Ocular Drug Delivery
  • Pulmonary Drug Delivery
  • Nasal Drug Delivery
  • Transmucosal Drug Delivery
  • Implantable Drug Delivery

By Application

  • Infectious Diseases
  • Cancer
  • Cardiovascular Diseases
  • Diabetes
  • Respiratory Diseases
  • Central Nervous System Disorders
  • Autoimmune Diseases
  • Other Applications


By End User

  • Hospitals
  • Home Care Settings
  • ASC/Clinics
  • Other End Users


By Country

  • North America
    • US
    • Canada
    • Mexico

 

Contact Us

Contact Person: Sameer Joshi 

Phone: +1-646-491-9876

Email Id: sales@theinsightpartners.com

Download PDF Brochure